Clinical trial NCT04702100: Instrument-assisted Soft Tissue Mobilization Versus Integrated on Mechanical Neck Pain
Official title: Instrument-assisted Soft Tissue Mobilization Versus Integrated Neuromuscular Inhibition Technique on Mechanical Non-specific Neck Pain
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Non-specific Chronic Mechanical Neck Pain
Keywords: instrument-assisted soft tissue mobilization
integrated neuromuscular inhibition technique
Lead sponsor: Cairo University
Sponsor class: OTHER
First posted: 2021-01-08
Enrollment: 90
Sex: ALL
Minimum age (years): 18
Maximum age (years): 35
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: instrument assisted soft tissue mobilization and integrated neuromuscular inhibition technique
Primary purpose: TREATMENT

Brief summary: the aim of this study is to investigate the efficacy of instrumented assisted soft tissue mobilization versus integrated neuromuscular inhibition technique on mechanical non-specific neck pain

Detailed description: Mechanical neck pain is a prevalent condition in various populations. Neck pain occurrence is affected by several factors, involving environmental, psychological, and social aspects. Neck pain represents the fourth major disorder responsible for a person's year lived with disability and ranked eleventh as disability-adjusted life years of a person. The neck pain incidence ranges from 10.4 to 23.3% in 1-year time, while the range of prevalence was 0.4 to 86.8%. It has a high prevalence among computer users, office workers, and females, especially females aged 35 to 49 years old. Myofascial trigger point (MTrP) might play an important role in the formation of mechanical neck pain and is known as a hyperirritable spot in skeletal muscle that is accompanied with a hypersensitive palpable nodule in a taut band. IASTM and integrated play an important role in the treatment of mechanical neck pain.this trial has three groups; one will receive IASTM+ conventional, the second will receive integrated + conventional and the third will receive conventional treatment for four week

Eligibility criteria: Inclusion Criteria:

1. diagnosed as non-specific neck pain with upper trapezius active myofascial trigger points less than 3 months of duration and have these criteria: taut band on palpation, hyper sensible tender spot in the taut band, local twitch response referred pain pattern
2. body mass index from 18 to 25 kg/m2
3. their ages from 18-35

Exclusion Criteria:

1. if they had trigger point injections within the past 6 months
2. history of neck or upper back surgery, trauma or fracture
3. history of a whiplash injury, skin diseases and lesions, any sensory disturbances, any vascular syndromes, neck and back deformities
4. cervical radiculopathy, and diagnosis of fibromyalgia syndrome, skin diseases

Primary outcomes:
measure: pain intensity
timeFrame: up to four weeks
Secondary outcomes:
measure: neck disability
timeFrame: up to four weeks
measure: muscle amplitude in the form of normalized root mean square (RMS)
timeFrame: up to four weeks
measure: muscle fatigue in the form of median frequency
timeFrame: up to four weeks
Other outcomes:
Locations:
city: Giza
country: Egypt
facility: Al Shaymaa Shaaban Abd El Azeim
Study officials:
References: